ChengDu ShengNuo Biotec Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	227.75	218.71	219.13	372.12	211.56	129.53
Trading Asset Securities	67	20.16	50	-	200	-
Cash & Short-Term Investments	294.75	238.86	269.13	372.12	411.56	129.53
Cash Growth	27.81%	-11.25%	-27.68%	-9.58%	217.74%	24.28%
Accounts Receivable	178.9	125.2	115.89	119.16	111.73	106.08
Other Receivables	6.67	7.97	10.27	23.63	9.49	0.38
Receivables	185.57	133.17	126.16	142.79	121.22	106.46
Inventory	330.25	304.75	194.33	135.43	101.36	90.01
Prepaid Expenses	-	-	0.22	-	-	3.13
Other Current Assets	55.23	41.42	19.47	15.54	17.85	6.96
Total Current Assets	865.79	718.21	609.3	665.89	652.01	336.09
Property, Plant & Equipment	761.68	727.43	483.86	285.1	238.06	200.47
Long-Term Investments	151.15	111.04	94.43	55.69	9.9	-
Other Intangible Assets	80.69	40.2	35.48	36.3	36.48	22.52
Long-Term Deferred Tax Assets	12.58	9.48	4.04	3.84	3.46	3.42
Long-Term Deferred Charges	17.97	14.1	19.98	15.43	10.93	5.96
Other Long-Term Assets	19.29	27.44	68.64	45.75	5.78	24.52
Total Assets	1,909	1,648	1,316	1,108	956.62	592.98
Accounts Payable	101.09	108.54	51.05	28.55	7.83	20.62
Accrued Expenses	17.09	47.46	48.12	57.01	49.65	57.53
Short-Term Debt	218.15	200.16	37.03	50.41	30.05	-
Current Portion of Long-Term Debt	169.7	99.63	34.05	2	-	-
Current Portion of Leases	-	0.6	0.82	0.75	0.68	-
Current Income Taxes Payable	10.4	2.61	8.74	5.07	4.19	1.86
Current Unearned Revenue	19.59	26.89	9.53	17.99	14.59	15.73
Other Current Liabilities	58.49	57.58	51.93	63.21	55.48	49.28
Total Current Liabilities	594.51	543.46	241.28	225	162.46	145.02
Long-Term Debt	180.25	182.03	189.19	48.05	-	-
Long-Term Leases	-	-	0.6	1.42	2.17	-
Long-Term Unearned Revenue	21.28	4.09	4.56	5.72	6.85	10.39
Long-Term Deferred Tax Liabilities	-	-	-	1.07	-	-
Total Liabilities	877.24	729.58	435.63	281.27	171.48	155.41
Common Stock	157.39	112.42	112	80	80	60
Additional Paid-In Capital	346.92	389.59	379.22	408.36	407.25	140.94
Retained Earnings	527.61	416.33	388.71	338.37	297.89	236.64
Total Common Equity	1,032	918.34	879.93	826.74	785.14	437.57
Minority Interest	-	-0.02	0.17	-	-	-
Shareholders' Equity	1,032	918.32	880.1	826.74	785.14	437.57
Total Liabilities & Equity	1,909	1,648	1,316	1,108	956.62	592.98
Total Debt	568.1	482.42	261.7	102.64	32.89	-
Net Cash (Debt)	-273.35	-243.56	7.43	269.48	378.68	129.53
Net Cash Growth	-	-	-97.24%	-28.84%	192.35%	24.83%
Net Cash Per Share	-1.70	-1.53	0.05	1.73	2.68	1.10
Filing Date Shares Outstanding	157.39	157.39	156.8	156.8	156.8	117.6
Total Common Shares Outstanding	157.39	157.39	156.8	156.8	156.8	117.6
Working Capital	271.28	174.75	368.03	440.89	489.55	191.07
Book Value Per Share	6.56	5.83	5.61	5.27	5.01	3.72
Tangible Book Value	951.22	878.15	844.45	790.44	748.66	415.05
Tangible Book Value Per Share	6.04	5.58	5.39	5.04	4.77	3.53
Buildings	-	235.44	104.44	101.29	96.46	61.14
Machinery	-	318.26	254.46	44.74	198.53	169.25
Construction In Progress	-	348.97	274.37	83.64	50.06	69.43

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.